News Related to SOTIO

Related coverage linked through entity extraction aliases.

LigaChem Accelerates ADC Pipeline Amid Losses, Lonza Expands Bioconjugate Capabilities

Apr 08, 2026

LigaChem Biosciences is expanding R&D investment in its ADC pipeline despite widening losses, with major clinical milestones expected this year. Concurrently, Lonza has enhanced its advanced synthesis capabilities for ADC development, including dual-payload technology and expanded Netherlands facility infrastructure.

Metastatic Prostate Cancer Clinical Trial Pipeline Expands with Multiple New Studies

Feb 14, 2026

Multiple pharmaceutical companies have initiated clinical trials for metastatic castration-resistant prostate cancer in February 2026, with over 180 companies developing 200+ pipeline therapies. Studies include combination therapies and novel drug candidates targeting advanced disease.